WW International, Inc.

WW International, Inc. is a global wellness company dedicated to inspiring healthy habits for real life and supporting individuals in achieving and maintaining their weight goals. Formerly known as Weight Watchers International, Inc., the company rebranded to reflect its broader focus on overall health and wellness. Headquartered in New York, NY, USA, WW operates with a mission to provide science-backed solutions for weight management.

The company offers a comprehensive suite of products and services, including digital subscription plans, in-person and virtual workshops, and personalized coaching, all built upon principles of behavioral science, nutrition guidance, and activity tracking. A significant development in its offerings is the expansion into clinical solutions, providing access to GLP-1 medications through its WeightWatchers Clinic and Med+ program, thereby integrating medical care with its established behavioral support.

Recent notable developments include leadership changes in April 2026, with CEO Tara Comonte's resignation and the establishment of an Interim Office of the CEO. The company continues to evolve its clinical offerings, recently expanding its Med+ program to include access to Novo Nordisk's Ozempic® pill, further solidifying its position in the integrated weight health ecosystem. In July 2025, WW International completed a financial reorganization, which strengthened its financial position and led to its relisting on Nasdaq.